Colon Cancer Surgery — Stages, Treatment & Prognosis
🏆 Expert Colon Cancer Care in Ahmedabad
Dr. Ruchir Bhavsar — one of Gujarat's leading GI oncosurgeons with 1000+ successful procedures. da Vinci certified robotic surgeon offering advanced laparoscopic and robotic colon cancer surgery at Gastroplus Hospital, Ahmedabad. 24/7 emergency cancer care available.
Colon cancer is the third most common cancer globally and requires expert surgical management for optimal outcomes. As a da Vinci certified GI oncosurgeon practicing in Ahmedabad, I've performed over 200 colon cancer surgeries using advanced laparoscopic and robotic techniques. This comprehensive guide covers everything patients need to know about colon cancer staging, surgical treatment options, and expected outcomes.
At Gastroplus Hospital, Ahmedabad, we provide multidisciplinary colon cancer care combining cutting-edge surgical techniques with personalized treatment planning. Our GI oncosurgery program ensures patients receive world-class care close to home.
Understanding Colon Cancer: Clinical Overview
Colon cancer, also called colorectal cancer when including the rectum, develops in the large intestine (colon). Most colon cancers begin as small, benign clumps of cells called polyps that can become cancerous over time.
Types of Colon Cancer
- Adenocarcinoma — 95% of colon cancers, arising from glandular cells
- Neuroendocrine tumors — Rare, often more aggressive
- Lymphomas — Primary lymphoid malignancies of the colon
- Sarcomas — Connective tissue tumors (very rare)
Risk Factors for Colon Cancer
- Age — 90% occur after age 50
- Family history — Hereditary syndromes (FAP, Lynch syndrome)
- Inflammatory bowel disease — Ulcerative colitis, Crohn's disease
- Lifestyle factors — High-fat diet, smoking, alcohol, obesity
- Previous polyps — History of adenomatous polyps
- Genetic mutations — APC, KRAS, p53 gene alterations
Symptoms and Early Detection
⚠️ When to See a Doctor Immediately
Seek urgent medical attention for: persistent blood in stool, severe abdominal pain, sudden bowel obstruction, or unexplained weight loss >5kg in 3 months. Early detection dramatically improves survival rates.
Colon Cancer Symptom Checklist
- Changes in bowel habits — Diarrhea, constipation, or stool consistency changes lasting >2 weeks
- Blood in stool — Bright red or dark, tarry stools
- Abdominal discomfort — Persistent cramps, gas, or pain
- Weight loss — Unexplained weight loss despite normal appetite
- Fatigue — Persistent weakness or tiredness
- Iron deficiency anemia — Without obvious bleeding source
- Incomplete bowel evacuation — Feeling that bowel doesn't empty completely
- Narrow stools — Persistent pencil-thin stools
Diagnostic Workup
As an experienced colorectal surgeon, I follow a systematic diagnostic approach:
- Clinical Assessment — Detailed history and physical examination
- Laboratory Tests — CBC, liver function, CEA tumor marker, genetic testing
- Colonoscopy — Gold standard for diagnosis and biopsy
- Imaging Studies — CT chest/abdomen/pelvis, MRI for rectal tumors
- Functional Assessment — Cardiac and pulmonary evaluation for surgery
- Molecular Testing — MSI status, KRAS/NRAS mutations for targeted therapy
Colon Cancer Staging System
Accurate staging is crucial for treatment planning. We use the TNM staging system combined with multidisciplinary tumor board discussions at Gastroplus Hospital.
TNM Classification System
| Component | Category | Description |
|---|---|---|
| T (Tumor) | Tis | Carcinoma in situ (intramucosal) |
| T1 | Tumor invades submucosa | |
| T2 | Tumor invades muscularis propria | |
| T3 | Tumor invades subserosa/pericolic fat | |
| T4 | Tumor invades adjacent organs (T4b) or perforates visceral peritoneum (T4a) | |
| N (Nodes) | N0 | No regional lymph node metastasis |
| N1 | 1-3 positive regional lymph nodes | |
| N2 | 4+ positive regional lymph nodes | |
| N2c | Tumor deposits in subserosa without lymph node metastasis | |
| M (Metastasis) | M0 | No distant metastasis |
| M1a | Metastasis to one distant organ/site | |
| M1b | Metastasis to multiple organs/sites |
AJCC Stage Groupings
| Stage | TNM | 5-Year Survival | Treatment Approach |
|---|---|---|---|
| 0 | Tis N0 M0 | 95-100% | Local excision or polypectomy |
| I | T1-T2 N0 M0 | 85-95% | Surgical resection alone |
| II | T3-T4 N0 M0 | 70-85% | Surgery ± adjuvant chemotherapy |
| III | Any T N1-N2 M0 | 45-70% | Surgery + adjuvant chemotherapy |
| IV | Any T Any N M1 | 5-15% | Systemic therapy ± surgery for selected cases |
Colon Cancer Treatment Algorithm
Treatment decisions are made through our multidisciplinary team approach at Gastroplus Hospital, considering tumor stage, patient fitness, molecular characteristics, and patient preferences.
Stage-Specific Treatment Protocols
Stage 0-I (Early Stage)
- T1 tumors — Endoscopic mucosal resection (EMR) if favorable features
- T1 with high-risk features — Formal oncologic resection
- T2 tumors — Standard oncologic resection (laparoscopic preferred)
- Lymph node sampling — Minimum 12 lymph nodes examined
Stage II (Locally Advanced)
- Standard approach — Oncologic resection with adequate margins
- High-risk features — Consider adjuvant chemotherapy (T4, perforation, poor differentiation, <12 lymph nodes, lymphovascular invasion)
- MSI-H tumors — Surgery alone may be adequate
- MSS tumors — Higher recurrence risk, consider adjuvant therapy
Stage III (Node-Positive)
- Standard treatment — Surgical resection followed by adjuvant chemotherapy
- Chemotherapy regimen — FOLFOX or CapeOX for 3-6 months
- Timing — Chemotherapy within 4-8 weeks post-surgery
- Duration — 3 months for low-risk, 6 months for high-risk patients
Stage IV (Metastatic)
- Resectable metastases — Neoadjuvant chemotherapy → surgery → adjuvant therapy